Witnessing the stock’s movement on the chart, on Wednesday, Cyclerion Therapeutics Inc (NASDAQ: CYCN) had a quiet start as it plunged -13.26% to $2.85, before settling in for the price of $3.28 at the close. Taking a more long-term approach, CYCN posted a 52-week range of $1.27-$9.47.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -33.97%. Meanwhile, its Annual Earning per share during the time was 36.06%. This publicly-traded company’s shares outstanding now amounts to $2.53 million, simultaneously with a float of $1.96 million. The organization now has a market capitalization sitting at $7.71 million. At the time of writing, stock’s 50-day Moving Average stood at $2.74, while the 200-day Moving Average is $2.87.
Cyclerion Therapeutics Inc (CYCN) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Cyclerion Therapeutics Inc’s current insider ownership accounts for 27.52%, in contrast to 20.98% institutional ownership. According to the most recent insider trade that took place on Nov 21 ’24, this organization’s 10% Owner sold 357,880 shares at the rate of 1.55, making the entire transaction reach 555,108 in total value, affecting insider ownership by 0.
Cyclerion Therapeutics Inc (CYCN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Cyclerion Therapeutics Inc (NASDAQ: CYCN) Trading Performance Indicators
Let’s observe the current performance indicators for Cyclerion Therapeutics Inc (CYCN). It’s Quick Ratio in the last reported quarter now stands at 5.07. The Stock has managed to achieve an average true range (ATR) of 0.94. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 40.58.
In the same vein, CYCN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.12.
Technical Analysis of Cyclerion Therapeutics Inc (CYCN)
Going through the that latest performance of [Cyclerion Therapeutics Inc, CYCN]. Its last 5-days volume of 0.24 million was inferior to the volume of 0.85 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 4.94% While, its Average True Range was 0.98.
Raw Stochastic average of Cyclerion Therapeutics Inc (CYCN) in the period of the previous 100 days is set at 19.21%, which indicates a major rise in contrast to 16.14% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 638.21% that was higher than 286.83% volatility it exhibited in the past 100-days period.
